Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial
Tirzepatide (the main component in Mounjaro) is approved for the treatment of obesity, however, when used for weight control the company that makes it (Lilly) calls it Zepbound
A history of pancreatitis, certain thyroid cancer concerns, pregnancy, or other contraindications requires careful review by the prescribing clinician
These visual changes indicate the peptide has broken down and the injection is no longer safe
While GLP-1 costs remain higher than bariatric surgery, retail prices will come down over time, especially in 2032 (when initial patents run out and generics appear), but probably not to the level of Dexatrim, phen-phen and similar blockbuster, yet faddish, weight-loss pills from yesteryear